Daily Rhythm in Plasma N-acetyltryptamine.

Peter S Backlund, Henryk F Urbanski, Mark A Doll, David W Hein, Marjan Bozinoski, Christopher E Mason, Steven L Coon, David C Klein
Author Information
  1. Peter S Backlund: Biomedical Mass Spectrometry Facility, Intramural Research Program.
  2. Henryk F Urbanski: Divisions of Neuroscience.
  3. Mark A Doll: Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.
  4. David W Hein: Department of Pharmacology and Toxicology and James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky.
  5. Marjan Bozinoski: Department of Physiology and Biophysics.
  6. Christopher E Mason: Department of Physiology and Biophysics.
  7. Steven L Coon: Section on Neuroendocrinology, Program in Developmental Endocrinology and Genetics.
  8. David C Klein: Section on Neuroendocrinology, Program in Developmental Endocrinology and Genetics.

Abstract

Normal physiology undergoes 24-h changes in function that include daily rhythms in circulating hormones, most notably melatonin and cortical steroids. This study focused on N-acetyltryptamine, a little-studied melatonin receptor mixed agonist-antagonist and the likely evolutionary precursor of melatonin. The central issue addressed was whether N-acetyltryptamine is physiologically present in the circulation. N-acetyltryptamine was detected by LC-MS/MS in daytime plasma of 3 different mammals in subnanomolar levels (mean �� SEM: rat, 0.29 �� 0.05 nM, n = 5; rhesus macaque, 0.54 �� 0.24 nM, n = 4; human, 0.03 �� 0.01 nM, n = 32). Analysis of 24-h blood collections from rhesus macaques revealed a nocturnal increase in plasma N-acetyltryptamine (p < 0.001), which varied from 2- to 15-fold over daytime levels among the 4 animals studied. Related RNA sequencing studies indicated that the transcript encoding the tryptamine acetylating enzyme arylalkylamine N-acetyltransferase (AANAT) is expressed at similar levels in the rhesus pineal gland and retina, thereby indicating that either tissue could contribute to circulating N-acetyltryptamine. The evidence that N-acetyltryptamine is a physiological component of mammalian blood and exhibits a daily rhythm, together with known effects as a melatonin receptor mixed agonist-antagonist, shifts the status of N-acetyltryptamine from pharmacological tool to candidate for a physiological role. This provides a new opportunity to extend our understanding of 24-h biology.

Keywords

References

  1. J Endocrinol. 2014 Aug;222(2):R39-59 [PMID: 24891434]
  2. J Pharmacol Exp Ther. 1985 Aug;234(2):395-401 [PMID: 2991499]
  3. J Pineal Res. 2015 Oct;59(3):354-64 [PMID: 26267754]
  4. J Biol Chem. 1999 Dec 3;274(49):34519-22 [PMID: 10574910]
  5. Pharmacol Rev. 2010 Sep;62(3):343-80 [PMID: 20605968]
  6. Nat Sci Sleep. 2009 Nov 04;1:1-8 [PMID: 23616692]
  7. Anal Biochem. 2001 Jan 1;288(1):106-8 [PMID: 11141315]
  8. Nat Biotechnol. 2014 Sep;32(9):915-925 [PMID: 25150835]
  9. Rejuvenation Res. 2014 Apr;17(2):150-3 [PMID: 24134213]
  10. Mol Cell Neurosci. 1993 Aug;4(4):310-8 [PMID: 19912938]
  11. Life Sci. 1975 Oct 10;17(7):1167-77 [PMID: 1081635]
  12. Science. 1970 Sep 11;169(3950):1093-5 [PMID: 4915470]
  13. Adv Exp Med Biol. 1991;294:255-65 [PMID: 1663311]
  14. Endocrinology. 1983 Nov;113(5):1582-6 [PMID: 6194975]
  15. Neuroendocrinology. 2011;93(4):211-22 [PMID: 21508622]
  16. Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):314-9 [PMID: 24351931]
  17. Pharmacogenetics. 2001 Aug;11(6):511-20 [PMID: 11505221]
  18. Chronobiol Int. 2006;23(1-2):381-91 [PMID: 16687311]
  19. Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):304-9 [PMID: 8990204]
  20. J Biol Chem. 2007 Feb 16;282(7):4233-7 [PMID: 17164235]
  21. Front Endocrinol (Lausanne). 2014 Jun 25;5:101 [PMID: 25009533]
  22. Endocrinology. 1999 Feb;140(2):972-8 [PMID: 9927331]
  23. Chronobiol Int. 2006;23(1-2):5-20 [PMID: 16687276]
  24. J Neurochem. 1988 Nov;51(5):1436-40 [PMID: 3171587]
  25. Genomics. 1996 May 15;34(1):76-84 [PMID: 8661026]
  26. Neurosci Lett. 1988 Dec 19;95(1-3):296-301 [PMID: 3226615]
  27. Pharmacogenetics. 1995 Feb;5(1):1-17 [PMID: 7773298]
  28. J Clin Endocrinol Metab. 2002 Oct;87(10):4699-706 [PMID: 12364461]
  29. Expert Opin Drug Metab Toxicol. 2009 Apr;5(4):353-66 [PMID: 19379125]
  30. Am J Physiol. 1968 Sep;215(3):611-9 [PMID: 5670999]
  31. Bioanalysis. 2013 Jun;5(11):1397-407 [PMID: 23742309]
  32. Bioessays. 2008 Jul;30(7):624-33 [PMID: 18536031]
  33. Endocrinology. 1979 Feb;104(2):295-301 [PMID: 109277]
  34. Endocrinology. 1992 Sep;131(3):1297-304 [PMID: 1324157]
  35. Pharmacogenetics. 2001 Apr;11(3):207-15 [PMID: 11337936]
  36. Age (Dordr). 2014 Feb;36(1):183-97 [PMID: 23881606]
  37. Neuroendocrinology. 1981 Apr;32(4):193-6 [PMID: 7194425]
  38. Adv Exp Med Biol. 2014;801:765-71 [PMID: 24664769]
  39. J Biol Rhythms. 2004 Aug;19(4):264-79 [PMID: 15245646]
  40. Science. 1995 Dec 8;270(5242):1681-3 [PMID: 7502081]
  41. J Endocrinol. 2009 May;201(2):275-85 [PMID: 19223397]
  42. Endocrinology. 1982 May;110(5):1766-72 [PMID: 6804211]
  43. BMC Evol Biol. 2010 May 25;10:154 [PMID: 20500864]
  44. Biol Signals Recept. 1999 Jan-Apr;8(1-2):79-83 [PMID: 10085467]
  45. Science. 1978 Aug 25;201(4357):741-3 [PMID: 675255]
  46. Neuroendocrinology. 1974;14(3):165-73 [PMID: 4368996]
  47. Nature. 1983 Dec 22-1984 Jan 4;306(5945):782-4 [PMID: 6656879]
  48. J Mass Spectrom. 2012 Mar;47(3):277-85 [PMID: 22431453]
  49. Biochim Biophys Acta. 1969 Jun 17;184(1):210-2 [PMID: 5791110]
  50. J Neurosci. 2006 Sep 6;26(36):9153-61 [PMID: 16957072]
  51. Brain Res. 1991 Jan 25;539(2):355-7 [PMID: 2054604]
  52. Gen Comp Endocrinol. 1994 Oct;96(1):19-26 [PMID: 7843564]
  53. Eur J Pharmacol. 1984 Oct 1;105(1-2):193-4 [PMID: 6489448]
  54. Br J Pharmacol. 1995 Feb;114(3):618-23 [PMID: 7735688]
  55. Eur J Neurosci. 1997 Apr;9(4):643-53 [PMID: 9153571]
  56. Br J Pharmacol. 1994 Jan;111(1):295-301 [PMID: 8012710]
  57. Physiol Rev. 1998 Jul;78(3):687-721 [PMID: 9674691]
  58. Prog Retin Eye Res. 2005 Jul;24(4):433-56 [PMID: 15845344]
  59. Endocrinology. 1977 Jul;101(1):119-27 [PMID: 862551]
  60. Biochem Pharmacol. 1968 Aug;17(8):1543-52 [PMID: 4386234]
  61. Chronobiol Int. 1989;6(1):93-102 [PMID: 2706705]
  62. J Neurochem. 1997 Jan;68(1):213-24 [PMID: 8978728]
  63. J Neurochem. 2011 Oct;119(1):6-17 [PMID: 21790603]
  64. Recent Prog Horm Res. 1997;52:307-57; discussion 357-8 [PMID: 9238858]

Grants

  1. R56 AG029612/NIA NIH HHS
  2. R01 AG029612/NIA NIH HHS
  3. ZIC HD001421-16/Intramural NIH HHS
  4. P51 OD011092/NIH HHS
  5. R01 AG036670/NIA NIH HHS

MeSH Term

Animals
Arylalkylamine N-Acetyltransferase
Circadian Rhythm
Gene Expression Profiling
Humans
Macaca mulatta
Male
Melatonin
Photoperiod
Pineal Gland
Rats
Retina
Tandem Mass Spectrometry
Tryptamines

Chemicals

Tryptamines
N-acetyltryptamine
Arylalkylamine N-Acetyltransferase
Melatonin